Literature DB >> 20526463

Social values and scientific evidence: the case of the HPV vaccines.

Kristen Intemann1, Inmaculada de Melo-Martín.   

Abstract

Several have argued that the aims of scientific research are not always independent of social and ethical values. Yet this is often assumed only to have implications for decisions about what is studied, or which research projects are funded, and not for methodological decisions or standards of evidence. Using the case of the recently developed HPV vaccines, we argue that the social aims of research can also play important roles in justifying decisions about (1) how research problems are defined in drug development, (2) evidentiary standards used in testing drug "success", and (3) clinical trial methodology. As a result, attending to the social aims at stake in particular research contexts will produce more rational methodological decisions as well as more socially relevant science.

Entities:  

Year:  2010        PMID: 20526463      PMCID: PMC2879703          DOI: 10.1007/s10539-009-9191-9

Source DB:  PubMed          Journal:  Biol Philos        ISSN: 0169-3867            Impact factor:   1.461


  30 in total

1.  Papillomavirus vaccines in perspective.

Authors:  Jessica A Kahn; Robert D Burk
Journal:  Lancet       Date:  2007-06-30       Impact factor: 79.321

Review 2.  The disparity of cervical cancer in diverse populations.

Authors:  Levi S Downs; Jennifer S Smith; Isabel Scarinci; Lisa Flowers; Groesbeck Parham
Journal:  Gynecol Oncol       Date:  2008-05       Impact factor: 5.482

3.  Global cancer statistics, 2002.

Authors:  D Max Parkin; Freddie Bray; J Ferlay; Paola Pisani
Journal:  CA Cancer J Clin       Date:  2005 Mar-Apr       Impact factor: 508.702

4.  Against which human papillomavirus types shall we vaccinate and screen? The international perspective.

Authors:  Nubia Muñoz; F Xavier Bosch; Xavier Castellsagué; Mireia Díaz; Silvia de Sanjose; Doudja Hammouda; Keerti V Shah; Chris J L M Meijer
Journal:  Int J Cancer       Date:  2004-08-20       Impact factor: 7.396

5.  Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases.

Authors:  Suzanne M Garland; Mauricio Hernandez-Avila; Cosette M Wheeler; Gonzalo Perez; Diane M Harper; Sepp Leodolter; Grace W K Tang; Daron G Ferris; Marc Steben; Janine Bryan; Frank J Taddeo; Radha Railkar; Mark T Esser; Heather L Sings; Micki Nelson; John Boslego; Carlos Sattler; Eliav Barr; Laura A Koutsky
Journal:  N Engl J Med       Date:  2007-05-10       Impact factor: 91.245

Review 6.  Vaccines against human papillomavirus: perspectives for controlling cervical cancer.

Authors:  Alejandro García Carrancá; Silvia C Galván
Journal:  Expert Rev Vaccines       Date:  2007-08       Impact factor: 5.217

7.  Salmonella enterica serovar Typhi Ty21a expressing human papillomavirus type 16 L1 as a potential live vaccine against cervical cancer and typhoid fever.

Authors:  Dominique Fraillery; David Baud; Susana Yuk-Ying Pang; John Schiller; Martine Bobst; Nathalie Zosso; Françoise Ponci; Denise Nardelli-Haefliger
Journal:  Clin Vaccine Immunol       Date:  2007-08-08

8.  Effect of human papillomavirus 16/18 L1 viruslike particle vaccine among young women with preexisting infection: a randomized trial.

Authors:  Allan Hildesheim; Rolando Herrero; Sholom Wacholder; Ana C Rodriguez; Diane Solomon; M Concepcion Bratti; John T Schiller; Paula Gonzalez; Gary Dubin; Carolina Porras; Silvia E Jimenez; Douglas R Lowy
Journal:  JAMA       Date:  2007-08-15       Impact factor: 56.272

9.  Impact of vaccination with Cervarix (trade mark) on subsequent HPV-16/18 infection and cervical disease in women 15-25 years of age.

Authors:  Diane M Harper
Journal:  Gynecol Oncol       Date:  2008-07-22       Impact factor: 5.482

10.  Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: a combined analysis of four randomised clinical trials.

Authors:  Kevin A Ault
Journal:  Lancet       Date:  2007-06-02       Impact factor: 79.321

View more
  2 in total

1.  Legitimizing Values in Regulatory Science.

Authors:  Manuela Fernández Pinto; Daniel J Hicks
Journal:  Environ Health Perspect       Date:  2019-03       Impact factor: 9.031

2.  Public engagement and argumentation in science.

Authors:  Silvia Ivani; Catarina Dutilh Novaes
Journal:  Eur J Philos Sci       Date:  2022-08-09       Impact factor: 1.602

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.